Article
|
Open Access
Featured
-
-
Article |
Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces
The development of a new genetic tool to selectively deplete or modify group 2 innate lymphoid cells (ILC2s) addresses the debate regarding the non-redundant functions of this immune cell type.
- Amy M. Tsou
- , Hiroshi Yano
- & David Artis
-
Article |
Discovery of bioactive microbial gene products in inflammatory bowel disease
A computational system termed MetaWIBELE (workflow to identify novel bioactive elements in the microbiome) is used to identify microbial gene products that are potentially bioactive and have a functional role in the pathogenesis of inflammatory bowel disease.
- Yancong Zhang
- , Amrisha Bhosle
- & Eric A. Franzosa
-
Article |
Immune regulation by fungal strain diversity in inflammatory bowel disease
Genetically diverse Candida albicans strains in patients with inflammatory bowel disease secrete a toxin and aggravate IL-1β-dependent intestinal inflammation.
- Xin V. Li
- , Irina Leonardi
- & Iliyan D. Iliev
-
Article
| Open AccessCells of the human intestinal tract mapped across space and time
Cells from embryonic, fetal, paediatric and adult human intestinal tissue are analysed at different locations along the intestinal tract to construct a single-cell atlas of the developing and adult human intestinal tract, encompassing all cell lineages.
- Rasa Elmentaite
- , Natsuhiko Kumasaka
- & Sarah A. Teichmann
-
Article |
Genome-wide enhancer maps link risk variants to disease genes
Mapping enhancer regulation across human cell types and tissues illuminates genome function and provides a resource to connect risk variants for common diseases to their molecular and cellular functions.
- Joseph Nasser
- , Drew T. Bergman
- & Jesse M. Engreitz
-
Article |
Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis
In patients with ulcerative colitis, chronic inflammation can lead to remodelling of the colorectal epithelium through positive selection of clones with mutations in genes related to IL-17 signalling, which, however, might be negatively selected during colitis-associated carcinogenesis.
- Nobuyuki Kakiuchi
- , Kenichi Yoshida
- & Seishi Ogawa
-
Article
| Open AccessMulti-omics of the gut microbial ecosystem in inflammatory bowel diseases
The Inflammatory Bowel Disease Multi’omics Database includes longitudinal data encompassing a multitude of analyses of stool, blood and biopsies of more than 100 individuals, and provides a comprehensive description of host and microbial activities in inflammatory bowel diseases.
- Jason Lloyd-Price
- , Cesar Arze
- & Curtis Huttenhower
-
Perspective
| Open AccessThe Integrative Human Microbiome Project
Over ten years, the Human Microbiome Project has provided resources for studying the microbiome and its relationship to disease; this Perspective summarizes the key achievements and findings of the project and its relationship to the broader field.
- Lita M. Proctor
- , Heather H. Creasy
- & Curtis Huttenhower
-
Article |
Colonic epithelial cell diversity in health and inflammatory bowel disease
Profiling of single epithelial cells in healthy and inflamed colons identifies specialized cellular subpopulations, including a type of goblet cell that secretes the antibacterial protein WFDC2, which preserves the integrity of the epithelial barrier layer.
- Kaushal Parikh
- , Agne Antanaviciute
- & Alison Simmons
-
Letter |
Moving beyond microbiome-wide associations to causal microbe identification
Triangulation of microbe–phenotype relationships is an effective method for reducing the noise inherent in microbiota studies and enabling identification of causal microbes of disease, which may be applicable to human microbiome studies.
- Neeraj K. Surana
- & Dennis L. Kasper
-
-
Outlook |
Q&A: Joel Weinstock
Helminths are worms that can live in the human intestine. Joel Weinstock, a gastroenterologist at Tufts Medical Center in Boston, Massachusetts, studies how they affect inflammation and the body's immune response. He spoke to Nature about how helminths might lead to treatments for inflammatory bowel disease (IBD).
- Neil Savage
-
Outlook |
Genetics: Clues in the code
Gene exploration is providing unexpected insights into inflammatory bowel disease, and getting scientists closer to finding treatments that target the biological mechanisms.
- Sarah DeWeerdt
-
Outlook |
Cell-based therapy: Cells on trial
Four regenerative and immune-system therapies taking on the toughest cases of inflammatory bowel disease.
- Eric Bender
-
Outlook |
Microbiota: Reseeding the gut
Transplants of faecal matter have done wonders for the treatment of certain gastrointestinal infections. Will they ever work for inflammatory bowel disease?
- Liam Drew
-
Letter |
Diet rapidly and reproducibly alters the human gut microbiome
Consuming diets rich in plant versus animal products changes the microbes found in the human gut within days, with important implications for our health and evolution.
- Lawrence A. David
- , Corinne F. Maurice
- & Peter J. Turnbaugh
-
Letter |
Paneth cells as a site of origin for intestinal inflammation
Variation in ATG16L1, a protein involved in autophagy, confers risk for Crohn’s disease, but mice with hypomorphic ATG16L1 activity do not develop spontaneous intestinal inflammation; this study shows that autophagy compensates for endoplasmic reticulum stress — common in inflammatory bowel disease epithelium — specifically in Paneth cells, with Crohn’s-disease-like inflammation of the ileum originating from this cell type when both pathways are compromised.
- Timon E. Adolph
- , Michal F. Tomczak
- & Richard S. Blumberg
-
Letter |
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
A meta-analysis of previous genome-wide association studies of Crohn’s disease and ulcerative colitis, the two most common forms of inflammatory bowel disease, with a combined total of more than 75,000 cases and controls, finds that most loci contribute to both phenotypes and other immune-mediated disorders.
- Luke Jostins
- , Stephan Ripke
- & Judy H Cho
-
Research Highlights |
Infection breaks truce
-
Research Highlights |
Inflamed guts boost bad bacteria
-
News & Views |
Fat, bile and gut microbes
Western-style diets could be contributing to the rapid increase in inflammatory bowel disease. New research suggests that dietary fat can alter bile composition and so favour the growth of pro-inflammatory gut microbes. See Letter p.104
- Peter J. Turnbaugh
-
News |
How microbes train our immune system
Gut bacteria coax T cells to see them as friends.
- Alla Katsnelson
-
Letter |
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
- Claudia Günther
- , Eva Martini
- & Christoph Becker
-
Letter |
FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation
- Patrick-Simon Welz
- , Andy Wullaert
- & Manolis Pasparakis
-
Review Article |
Genetics and pathogenesis of inflammatory bowel disease
- Bernard Khor
- , Agnès Gardet
- & Ramnik J. Xavier
-
Review Article |
Intestinal homeostasis and its breakdown in inflammatory bowel disease
- Kevin J. Maloy
- & Fiona Powrie
-
News & Views |
The sound of silence
There are various ways in which apparently 'silent' DNA mutations — those that don't result in a change in the encoded protein — have untoward consequences. A striking example has emerged in a study of Crohn's disease.
- Laurence D. Hurst
-
Research Highlights |
Microbiology: Bacterial resettlement
-
News & Views |
Genes, viruses and microbes
Variations in several genes can increase an individual's susceptibility to complex disorders. But what tips the balance to cause the full-blown disease? For Crohn's disease, viruses could provide part of the answer.
- Alison Simmons
-
Research Highlights |
Immunology: Gene plus virus